Company Filing History:
Years Active: 1988-1990
Title: The Innovative Contributions of Beverly M. Fleming
Introduction
Beverly M. Fleming is a notable inventor based in Raleigh, NC, who has made significant contributions to the field of biotechnology. With a total of 3 patents to her name, she has developed innovative solutions that enhance the capabilities of various assays and liposome compositions.
Latest Patents
One of her latest patents is focused on the "Storage and use of liposomes." This invention relates to liposome compositions comprising liposomes in an aqueous buffer at a pH of 6.5-8.5, including a polyol in an amount of from 0.6 to 1.5 g per 100 ml of buffer. Additionally, it involves liposome compositions that include a detectable marker, allowing for derivatization with a ligand for use in assays targeting specific analytes. Another significant patent is the "Vacuum actuated assay device and method of using same." This invention describes a method for analyzing an analyte using an assay device that includes an assay component affixed to a permeable membrane. The device is designed to establish fluid communication between a preevacuated container and the assay component, ensuring efficient liquid passage through the membrane while maintaining vacuum integrity.
Career Highlights
Beverly M. Fleming is currently employed at Becton Dickinson and Company Limited, where she continues to innovate and contribute to advancements in medical technology. Her work has been instrumental in developing devices and methods that improve the accuracy and efficiency of assays.
Collaborations
Throughout her career, Beverly has collaborated with esteemed colleagues, including Daniel A. McLaurin and James P. O'Connell. These partnerships have fostered a collaborative environment that enhances the development of innovative solutions in her field.
Conclusion
Beverly M. Fleming's contributions to biotechnology through her patents and work at Becton Dickinson and Company Limited highlight her role as a leading inventor. Her innovative approaches to liposome compositions and assay devices continue to impact the industry positively.